Intrinsic Value of S&P & Nasdaq Contact Us

ERYTECH Pharma S.A. ERYP NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • FR • USD

SharesGrow Score
44/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ERYP

ERYTECH Pharma S.A. (ERYP) has a market capitalization of $47.38M and trades at $0.78. The 52-week range is 0.3-1.472.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -105.4, Earnings Per Share (EPS) of $-0.01.

The stock has a beta of 2.13, operates in the Healthcare sector.

Trading Data
Current Price$0.78
52-Week Range0.3-1.472
Volume3.21K
Avg Volume (30D)148.59K
Market Cap$47.38M
Beta (1Y)2.13
Company
IPO Date2016-07-05
Employees49
CEOGil Beyen
CountryFR
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS29604W1080
CUSIP29604W108
Income (Latest Year)
EBITDA$-22.69M
Operating Income$-2.8M
Net Income$-228K
EPS$-0.01
EPS Diluted$-0.01
Shares Outstanding$31.02M
Balance Sheet (Latest Year)
Total Assets$45.81M
Current Assets$42.63M
Cash & ST Investments$38.83M
Total Liabilities$22.33M
Total Debt$13.57M
Net Debt$-25.22M
Total Equity$23.49M
Debt / Equity0.58
Valuation Ratios
P/E Ratio-105.4
P/B Ratio2.02
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message